This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Sbi Pharmaceuticals Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Toshihiko Kuroiwa
Introduction
Toshihiko Kuroiwa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in the area of mitochondrial dysfunction brain diseases. His work has the potential to impact the treatment and diagnosis of various neurological conditions.
Latest Patents
Kuroiwa holds a patent for a therapeutic agent and diagnostic agent aimed at addressing mitochondrial dysfunction brain diseases, including cerebral infarction. The patent describes a therapeutic agent that comprises (A) δ-aminolevulinic acid or its derivatives and (B) an iron compound. This innovative approach could provide new avenues for treatment in this critical area of health.
Career Highlights
Kuroiwa is associated with Sbi Pharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients suffering from complex brain diseases.
Collaborations
He has collaborated with notable colleagues such as Yoshinaga Kajimoto and Takahiro Masubuchi, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Toshihiko Kuroiwa's contributions to the field of medical science through his patent and collaborative efforts highlight his role as an influential inventor. His work promises to enhance the understanding and treatment of mitochondrial dysfunction brain diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile